Tag: Abhay Gandhi
Sun Pharma’s NDA for Deuruxolitinib garners FDA nod: A potential leap for alopecia areata patients
Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their investigational drug, ... Read More
Sun Pharma gains Health Canada’s approval for WINLEVI for acne treatment
Sun Pharma Canada, a subsidiary of Sun Pharmaceutical Industries, has secured Health Canada's approval for their pioneering acne treatment, WINLEVI (clascoterone cream 1%). This marks ... Read More
Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise
India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More
Sun Pharmaceutical gets SEZABY FDA approval for neonatal seizures
Sun Pharmaceutical Industries has secured approval for SEZABY (phenobarbital sodium powder for injection) from the US Food and Drug Administration (FDA) for the treatment of ... Read More
Sun Pharma announces CEQUA FDA approval for dry eye treatment
CEQUA FDA approval : Sun Pharmaceutical Industries has secured approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the US Food and Drug Administration (FDA) to ... Read More